Advances in Hematology

Editorial Board

Academic Editors

  • Samir K. Ballas , Thomas Jefferson University, USA
  • Meral Beksac , Ankara University, Turkey
  • Suparno Chakrabarti , Manashi Chakrabarti Foundation, India
  • Francesco Dazzi, Imperial College, United Kingdom
  • Elvira Grandone, Portale dell'Opera di Padre Pio, Italy
  • Debra A. Hoppensteadt , Loyola University, USA
  • Yuzuru Kanakura, Osaka University, Japan
  • Shaji Kumar , Mayo Clinic, USA
  • Giancarlo M. Liumbruno , Italian National Blood Centre, Italy
  • Bashir A. Lwaleed , University of Southampton, United Kingdom
  • Estella M. Matutes , The Institute of Cancer Research, United Kingdom
  • Emili Montserrat, University of Barcelona, Spain
  • Andreas Neubauer, Philipps-Universität Marburg, Germany
  • Helen A. Papadaki, Heraklion University, Greece
  • Lawrence Rice , Baylor College of Medicine, USA
  • Aldo M. Roccaro, ASST Spedali Civili di Brescia, Italy
  • Shimon Slavin, The International Center for Cell Therapy & Cancer Immunotherapy, Israel
  • Erwin Strasser , Universität Erlangen-Nürnberg, Germany
  • David Varon, Hadassah-Hebrew University Medical Center, Israel
  • David H. Vesole, Hackensack Meridian Health, USA
    Advances in Hematology
     Journal metrics
    Acceptance rate8%
    Submission to final decision77 days
    Acceptance to publication25 days
    Impact Factor-

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.